year 13, Issue 3 (July - August 2019)
Iran J Med Microbiol 2019, 13(3): 194-209 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahimi N, Honarmand Jahromy S, Zare Karizi S. Evaluation of Antibiotic Resistance Pattern of Meropenem and Piperacillin- Tazobactam in Multi Drug Resistant Acinetobacter baumannii Isolates by Flow Cytometry Method. Iran J Med Microbiol 2019; 13 (3) :194-209
URL: http://ijmm.ir/article-1-955-en.html
URL: http://ijmm.ir/article-1-955-en.html
1- Department of Microbiology, School of Biological Sciences, Varamin- Pishva Branch, Islamic Azad University, Varamin, Iran
2- Department of Microbiology, School of Biological Sciences, Varamin-Pishva Branch, Islamic Azad University, Varamin, Iran , sahar_hj2@yahoo.com
3- Department of Genetics, School of Biological Sciences, Varamin-Pishva Branch, Islamic Azad University, Varamin, Iran
2- Department of Microbiology, School of Biological Sciences, Varamin-Pishva Branch, Islamic Azad University, Varamin, Iran , sahar_hj2@yahoo.com
3- Department of Genetics, School of Biological Sciences, Varamin-Pishva Branch, Islamic Azad University, Varamin, Iran
Abstract: (6239 Views)
Background and Aims: Flow cytometry is a rapid method that can analyze thousands of cells per second and can be used for determination of microbial populations and determination of bacterial antimicrobial susceptibility. In this study antibiotic resistance pattern of Acinetobacter baumannii isolates by flow cytometer was evaluated.
Materials and Methods: 55 isolates of Acinetobacter baumannii were isolated from clinical specimen of patients and were identified by biochemical tests. Antibiotic resistance patterns were studied by disc diffusion method and MDR strains were selected. MIC of Meropenem and Piperacillin were determined. Also antibiotic resistance pattern of isolates was determined by coloring with Rhodamine-123 and flow cytometry.
Results: 98% of isolates were MDR. The MIC ranges for maropenem were 8 - 256 μg/mL and for piperacillin were 128-1024 μg/mL. By flow cytometry it was demonstrated that at concentrations of 8, 4 and 2 μg/mL of meropenem, only 1.96%, 1.44% and 0.59%, of cells were killed respectively. At concentrations of 64,128 and 16 μg/mL of piperacillin, 13.8%, 11.3% and 5.9%of cells were killed respectively. Reducing the number of living bacteria was observed with increasing concentrations of both antibiotics.
Conclusion: The similarity between the results of flow cytometry and both agar and broth antibacterial susceptibility methods showed flow cytometry as a reliable and rapid test that can be used for this purpose.
Materials and Methods: 55 isolates of Acinetobacter baumannii were isolated from clinical specimen of patients and were identified by biochemical tests. Antibiotic resistance patterns were studied by disc diffusion method and MDR strains were selected. MIC of Meropenem and Piperacillin were determined. Also antibiotic resistance pattern of isolates was determined by coloring with Rhodamine-123 and flow cytometry.
Results: 98% of isolates were MDR. The MIC ranges for maropenem were 8 - 256 μg/mL and for piperacillin were 128-1024 μg/mL. By flow cytometry it was demonstrated that at concentrations of 8, 4 and 2 μg/mL of meropenem, only 1.96%, 1.44% and 0.59%, of cells were killed respectively. At concentrations of 64,128 and 16 μg/mL of piperacillin, 13.8%, 11.3% and 5.9%of cells were killed respectively. Reducing the number of living bacteria was observed with increasing concentrations of both antibiotics.
Conclusion: The similarity between the results of flow cytometry and both agar and broth antibacterial susceptibility methods showed flow cytometry as a reliable and rapid test that can be used for this purpose.
Type of Study: Original Research Article |
Subject:
Antibiotic Resistance
Received: 2019/08/9 | Accepted: 2019/11/22 | ePublished: 2019/11/22
Received: 2019/08/9 | Accepted: 2019/11/22 | ePublished: 2019/11/22
References
1. Veal DA, Deere D, Ferrari B, Piper J, Attfield PV. Fluorescence staining and flow cytometry for monitoring microbial cells. Journal of Immunological Methods. 2000; 243:220-191. [DOI:10.1016/S0022-1759(00)00234-9]
2. Nuding S, Zabel LT. Detection, identification, and susceptibility testing of bacteria by flow cytometry. Journal of Bacteriology & Parasitology. 2013; S5-005. Doi: 10(4172):2155-9597 [DOI:10.4172/2155-9597.S5-005]
3. Kansanaho H, Isonen-Sjölund N, Pietilä K, Airaksinen M, Isonen T. Patient counselling profile in a Finnish pharmacy. Patient Education and Counseling. 2002; 47(1):77-82. [DOI:10.1016/S0738-3991(01)00180-X]
4. Huang TH, Ning X, Wang X, Murthy N, Tzeng YL, Dickson RM. Rapid cytometric antibiotic susceptibility testing utilizing adaptive multidimensional statistical metrics. Analytical chemistry. 2015; 87(3):1941-9. [DOI:10.1021/ac504241x] [PMID] [PMCID]
5. Wu L, Wang S, Song Y, Wang X, Yan X. Applications and challenges for single-bacteria analysis by flow cytometry. Science China Chemistry. 2016; 59(1):30-9. [DOI:10.1007/s11426-015-5518-3]
6. Fraser D, Kaern M. A chance at survival: gene expression noise and phenotypic diversification strategies. Molecular Microbiology. 2009; 71(6):1333-40. [DOI:10.1111/j.1365-2958.2009.06605.x] [PMID]
7. Rainey PB, Beaumont HJ, Ferguson GC, Gallie J, Kost C, Libby E, et al. The evolutionary emergence of stochastic phenotype switching in bacteria. 2011. 2011; 10(Suppl 1):S14. [DOI:10.1186/1475-2859-10-S1-S14] [PMID] [PMCID]
8. Paau AS Cowles JR, Oro J. Flow-microfluorometric analysis of Escherichia coli, Rhizobium meliloti, and Rhizobium japonicum at different stages of the growth cycle. Canadian journal of microbiology. 1977; 23(9):1165-9. [DOI:10.1139/m77-175] [PMID]
9. Hutter KJ, Eipel H. Microbial determinations by flow cytometry. Microbiology. 1979; 113(2):369-75. [DOI:10.1099/00221287-113-2-369] [PMID]
10. Haugland RP. Handbook of fluorescent probes and research chemicals. Eugene: Molecular Probes Inc.; 1996.
11. Shapiro HM. Microbial analysis at the single-cell level: tasks and techniques. Journal of Microbiological Methods. 2000; 42(1):3-16. [DOI:10.1016/S0167-7012(00)00167-6]
12. Sack U, Tárnok A, Rothe G. Cellular diagnostics: basic principles, methods and clinical applications of flow cytometry. Basel: Karger Medical and Scientific Publishers; 2009. [DOI:10.1159/isbn.978-3-8055-8556-9]
13. Suller M, Stark J, Lloyd D. A flow cytometric study of antibiotic-induced damage and evaluation as a rapid antibiotic susceptibility test for methicillin-resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy. 1997; 40(1):77-83. [DOI:10.1093/jac/40.1.77] [PMID]
14. Mason D, Allman R, Stark J, Lloyd D. Rapid estimation of bacterial antibiotic susceptibility with flow cytometry. Journal of Microscopy. 1994; 176(1):8-16. [DOI:10.1111/j.1365-2818.1994.tb03494.x] [PMID]
15. Suller M, Lloyd D. Fluorescence monitoring of antibiotic‐induced bacterial damage using flow cytometry. Cytometry: The Journal of the International Society for Analytical Cytology. 1999; 35(3):235-41.
https://doi.org/10.1002/(SICI)1097-0320(19990301)35:3<235::AID-CYTO6>3.0.CO;2-0 [DOI:10.1002/(SICI)1097-0320(19990301)35:33.0.CO;2-0]
16. Gauthier C, Pierre STY, Villemure R. Rapid antimicrobial susceptibility testing of urinary tract isolates and samples by flow cytometry. Journal of Medical Microbiology.2002; 51:192-200. [DOI:10.1099/0022-1317-51-3-192] [PMID]
17. Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis. Critical Care. 2016; 20(1):221. [DOI:10.1186/s13054-016-1392-4] [PMID] [PMCID]
18. Visca P, Seifert H, Towner KJ. Acinetobacter infection-an emerging threat to human health. IUBMB life. 2011; 63(12):1048-54.
https://doi.org/10.1002/iub.534 [DOI:10.1002/iub.600] [PMID]
19. McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiology Review. 2013; 37(2):130-55. [DOI:10.1111/j.1574-6976.2012.00344.x] [PMID]
20. Falagas ME, Karveli EA.The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clinical Microbiology and Infection. 2007; 13(2):117-9. [DOI:10.1111/j.1469-0691.2006.01596.x] [PMID]
21. Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Critical Care. 2006; 10(2):R48. [DOI:10.1186/cc4869] [PMID] [PMCID]
22. Karbasizade V, Heidari L. Antimicrobial resistance of Acinetobacter baumannii isolated from Intensive Care Units of Isfahan hospitals, Iran. Journal of Isfahan Medical School. 2012; 30(191).
23. Ardebili A, Lari AR, Talebi M. Correlation of ciprofloxacin resistance with the AdeABC efflux system in Acinetobacter baumannii clinical isolates. Annals of Laboratory Medicine. 2014; 34(6):433-8. [DOI:10.3343/alm.2014.34.6.433] [PMID] [PMCID]
24. Moradi J, Hashemi FB, Bahador A. Antibiotic resistance of Acinetobacter baumannii in Iran: a systemic review of the published literature. Osong Public Health and Research Perspectives.2015;6(2):79-86. [DOI:10.1016/j.phrp.2014.12.006] [PMID] [PMCID]
25. Ghasemian R, Ahanjan M, Fatehi E, Shokri M. Prevalence and antibiotic resistance pattern of Acinetobacter isolated from patients admitted in ICUs in Mazandaran, Northern Iran. Global Journal of Health Science. 2016; 11(8):112-9. [DOI:10.5539/gjhs.v8n11p112]
26. Heinemann JA, Ankenbauer RG, Amábile-Cuevas CF. Do antibiotics maintain antibiotic resistance? Drug Discovery Today. 2000; 5(5):195-204. [DOI:10.1016/S1359-6446(00)01483-5]
27. Comas J,Vives-Rego J. Assessment of the effects of gramicidin, formaldehyde, and surfactants on Escherichia coli by flow cytometry using nucleic acid and membrane potential dyes. Cytometry.1997; 29:58-64.
https://doi.org/10.1002/(SICI)1097-0320(19970901)29:1<58::AID-CYTO6>3.0.CO;2-9 [DOI:10.1002/(SICI)1097-0320(19970901)29:13.0.CO;2-9]
28. Walberg M, Steent HB. Flow cytometric monitoring of bacterial susceptibility to antibiotics. Methods in Cell Biology. 2001; 64:553-66. [DOI:10.1016/S0091-679X(01)64029-9]
29. Soejima T, Minami JI, Iwatsuki K. The exclusive use of flow cytometry to evaluate the antibiotic-susceptibility. Biochimica et Biophysica Acta (BBA)-General Subjects. 2012; 1820(12):1980-6. [DOI:10.1016/j.bbagen.2012.09.003] [PMID]
30. Saint-Ruf C, Crussard S, Franceschi C, Orenga S, Ouattara J, Ramjeet M, et al. Antibiotic susceptibility testing of the gram-negative bacteria based on flow cytometry. Frontiers in Microbiology. 2016; 7:1121. [DOI:10.3389/fmicb.2016.01121] [PMID] [PMCID]
31. Huang TH, Ning X, Wang X, Murthy N, Tzeng YL, Dickson RM. Rapid cytometric antibiotic susceptibility testing utilizing adaptive multidimensional statistical metrics. Analytical Chemistry. 2015; 87(3):1941-9. [DOI:10.1021/ac504241x] [PMID] [PMCID]
32. Huang TH, Tzeng Y, Land Dickson R. FAST: Rapid Determinations of Antibiotic Susceptibility Phenotypes using Label-Free. Cytometry Cytometry A . 2018; 93(6):63948. [DOI:10.1002/cyto.a.23370] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
Iranian Journal of Medical Microbiology by Farname is licensed under CC BY-NC 4.0
